Navigation Links
Study involving more than 100 scientists provides new insights on green algae
Date:10/11/2007

Culminating a three-year research project, 115 scientists from around the world report in the Oct. 12 issue of the journal Science a "gold mine" of data on a tiny green alga called Chlamydomonas, with implications for human diseases.

The single-celled Chlamydomonas, a slimy organism that grows in soil and ponds, has approximately 15,000 genes, and scientists now know 95 percent of the sequence of its genome. Several years ago, they knew less than 2 percent.

"It's like having a dictionary of genes," said lead author Sabeeha Merchant, professor of biochemistry and associate director of UCLA's Molecular Biology Institute, who has studied the green alga for 20 years. "We know the words and now we want to learn to talk. Without the dictionary, you would be stuck and couldn't learn how to speak or write. We went from having a 200-word vocabulary to a 14,250-word vocabulary. Each of us is trying to learn how to put the words and sentences together in our own research programs.

"Having the genome sequence available fast-forwards our research by 10 or 20 years and allows us to make progress by leaps and bounds," she said. "The genome sequence opens the door for us to access all the genes and target our research on subsets of genes. What was just a dream 10 years ago, we have now accomplished."

Chlamydomonas' genes are likely to contain a wealth of data about the common ancestry of plants and animals, according to the international teams of scientists who compared its genes to those of plants and humans and other animals. The scientists report that the alga has maintained many genes that were lost during the evolution of land plants, has others associated with functions in humans and has numerous genes whose functions are unknown but which are associated with critical metabolic processes.

The alga turns out to be remarkably complex.

"Its single cell does much of the biochemistry that more complex organisms do," Merchant said. "It has to swim, find food, do photosynthesis and respiration, and it mates.

Chlamydomonas performs photosynthesis like plants, by converting carbon dioxide, water and the energy of sunlight into oxygen and sugars. Indeed, much of what is known about photosynthesis was learned from Chlamydomonas.

"Now we have learned that we don't know everything about photosynthesis and that there are still many unknown proteins," Merchant said. "We found many proteins involved in antioxidant function. Photosynthesis generates the most powerful oxidants known in biology; there has to be a protection mechanism because oxidation causes aging. In Chlamydomonas, proteins and lipids can get oxidized if reactions of photosynthesis are not properly controlled. We discovered a number of proteins that may be important for protection against oxidative damage."

The scientists identified 349 genes that are present in algae and plants but not in humans and other animals. More than 200 of these genes have unknown functions, a fact that surprises the researchers.

"It's exciting that most of these genes are unknown," Merchant said, adding that the scientists suspect that many of these genes are involved in photosynthesis.

"We don't know what they do yet; we hope to learn what they do," she said.

The scientists identified many new proteins that are likely associated with cilia thin organelles that allow a cell to sense its environment and tell where it is and they differentiated proteins that are critical for movement from those associated with sensory functions. The cilia provide locomotion and act as a cellular antenna.

Humans also have cilia in the brain, lungs and kidneys. The cilia are required for brain function in animals, and for metabolism. The loss of cilia leads to serious diseases, although scientists do not yet know why, Merchant said. Cilia perform key functions for a large number of organs, and the consequences of mutations can be severe. Embryos that lack cilia die very early in development. Model organisms like Chlamydomonas are ideal for discovering how cilia work and what goes wrong when they do not function properly.

The researchers have gleaned new insights about human diseases associated with dysfunction in human cilia, including diseases of the kidney and the eye.

The scientists from the United States, France, China, Japan, Germany, Australia and elsewhere can now predict what many of Chlamydomonas' genes do.

Co-authors on the paper include Simon Prochnik and Daniel Rokhsar of the U.S. Department of Energy's Joint Genome Institute and Arthur Grossman of the Carnegie Institution of Washington.

"We curate and catalog genes like an art curator curates works of art," Merchant said.

"An organism is more than the sum of its parts, but historically we've been able to look at only the little parts," she said. "In the genome age of biology, we can now analyze the whole organism. Now we can look at the whole organism and can figure out how the parts are linked. As a result of this project, we understand the organism much more and have a much better understanding of the connections, and we have tools to learn even more."

The Joint Genome Institute determined the genome sequence to discover what Chlamydomonas' DNA encodes.

While not the common ancestor of plants and animals, Chlamydomonas retains genes and proteins from the common ancestor, Merchant said.

The researchers performed a comparative gene analysis across species to explore the evolutionary history of Chlamydomonas and its relationship to other organisms. Of the 6,968 protein families that have so-called "homologs" proteins that have similar amino acid sequences, often reflecting a similar or related function among the species they found that Chlamydomonas shares 35 percent with both flowering plants and humans and an additional 10 percent with humans but not with flowering plants.

Chlamydomonas has many proteins that make it well-suited to living in the soil, including large families of specific transporters proteins that help move material across cell membranes which enable it to scavenge nutrients from soil. While some of these transporters have an affiliation with transporters in plants, others are more closely related to those in animals. There are also numerous genes and gene families that relate to making sugars and polysaccharides, to using the sugars and polysaccharides to produce energy, and to building a highly structured and efficient chloroplast, the factory where the cell harnesses the energy of sunlight.

The scientists identified protein families that are shared by Chlamydomonas, flowering plants and other algae but are not present in nonphotosynthetic organisms. This research led them to identify photosynthesis-related proteins conserved across the plant kingdom, with many even conserved in ancient cyanobacteria. The majority of the identified proteins have unknown functions but are probably critical since they have been exclusively maintained in photosynthetic organisms over nearly the entire period that life has existed on Earth.

Mechanisms that apply in algae also apply in many other forms of life and in other kinds of cells, including those of plants and mammals.

"We study algae to understand how cells work," Merchant said. "It's easier to conduct research with a microorganism."


'/>"/>

Contact: Stuart Wolpert
swolpert@support.ucla.edu
310-206-0511
University of California - Los Angeles
Source:Eurekalert

Related biology news :

1. Bioartificial kidney under study at MCG
2. Novel Asthma Study Shows Multiple Genetic Input Required; Single-gene Solution Shot Down
3. W.M. Keck Foundation funds study of friendly microbes
4. Yellowstone microbes fueled by hydrogen, according to U. of Colorado study
5. Emory Study Tests Bone Marrow Stem Cells to Improve Circulation in Legs
6. UCLA Study Shows One-Third of Drug Ads in Medical Journals Do Not Contain References Supporting Medical Claims
7. Study Demonstrates Gene Expression Microarrays are Comparable and Reproducible
8. Study Links Ebola Outbreaks To Animal Carcasses
9. Genome-wide mouse study yields link to human leukemia
10. Breakthrough Microarray-based Technology for the Study of Cancer
11. NYU Study Reveals How Brains Immune System Fights Viral Encephalitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2017)... , March 30, 2017  On April 6-7, 2017, ... the Genome hackathon at Microsoft,s headquarters in ... competition will focus on developing health and wellness apps ... Hack the Genome is the first hackathon ... The world,s largest companies in the genomics, tech and ...
(Date:3/28/2017)... March 28, 2017 The report ... (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, VMS), ... - Global Forecast to 2022", published by MarketsandMarkets, the ... and is projected to reach USD 75.64 Billion by ... 2022. The base year considered for the study is ...
(Date:3/23/2017)... , March 23, 2017 The report "Gesture Recognition ... Biometric), Industry, and Geography - Global Forecast to 2022", published by MarketsandMarkets, the ... a CAGR of 29.63% between 2017 and 2022. ... ... ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... SARASOTA, FL (PRWEB) , ... ... ... Inc. (RPS®) today announces publication of a United States multicenter, prospective clinical ... single use, disposable, point-of-care diagnostic test capable of identifying clinically significant acute ...
(Date:10/11/2017)... LINDA, CA (PRWEB) , ... October 11, 2017 ... ... to upregulate any gene in its endogenous context, enabling overexpression experiments and avoiding ... (CRISPRa) system with small RNA guides is transformative for performing systematic gain-of-function studies. ...
(Date:10/11/2017)... HILLS, Calif. , Oct. 11, 2017  SkylineDx today ... (ICR) and University of Leeds ... risk-stratify patients with multiple myeloma (MM), in a multi-centric Phase ... University of Leeds is the sponsor ... and ICR will perform the testing services to include high-risk ...
(Date:10/10/2017)... , ... October 10, 2017 ... ... cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing ... HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s ...
Breaking Biology Technology: